126 related articles for article (PubMed ID: 38071859)
1. Utility of incorporation of beta-D-glucan and T2Candida testing for diagnosis and treatment of candidemia.
Zacharioudakis IM; Zervou FN; Marsh K; Siegfried J; Yang J; Decano A; Dubrovskaya Y; Mazo D; Aguero-Rosenfeld M
Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116107. PubMed ID: 38071859
[TBL] [Abstract][Full Text] [Related]
2. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit.
Gill CM; Kenney RM; Hencken L; Mlynarek ME; Alangaden GJ; Samuel LP; Davis SL
Diagn Microbiol Infect Dis; 2019 Oct; 95(2):162-165. PubMed ID: 31248660
[TBL] [Abstract][Full Text] [Related]
3. Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia.
Träger J; Dräger S; Mihai S; Cipa F; Busse Grawitz A; Epting T; Meyer R; Rappold E; Held J
J Clin Microbiol; 2023 Nov; 61(11):e0059823. PubMed ID: 37823667
[TBL] [Abstract][Full Text] [Related]
4. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
[TBL] [Abstract][Full Text] [Related]
5. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
[TBL] [Abstract][Full Text] [Related]
6. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
Forster J; Dichtl K; Wagener J
Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults With Candidemia: A 5-year Experience in a Tertiary Hospital.
Agnelli C; Bouza E; Del Carmen Martínez-Jiménez M; Navarro R; Valerio M; Machado M; Guinea J; Sánchez-Carrillo C; Alonso R; Muñoz P
Clin Infect Dis; 2020 Apr; 70(9):1925-1932. PubMed ID: 31680136
[TBL] [Abstract][Full Text] [Related]
8. Rapid diagnosis of invasive candidiasis: ready for prime-time?
Clancy CJ; Nguyen MH
Curr Opin Infect Dis; 2019 Dec; 32(6):546-552. PubMed ID: 31567567
[TBL] [Abstract][Full Text] [Related]
9. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.
Mikulska M; Ullah N; Magnasco L; Codda G; Bartalucci C; Miletich F; Sepulcri C; Willison E; Vena A; Giacobbe DR; di Pilato V; Robba C; Ball L; Marchese A; Bassetti M
Clin Microbiol Infect; 2024 Jun; 30(6):822-827. PubMed ID: 38431255
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
11. Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
Prüller F; Wagner J; Raggam RB; Hoenigl M; Kessler HH; Truschnig-Wilders M; Krause R
Med Mycol; 2014 Jul; 52(5):455-61. PubMed ID: 24906361
[TBL] [Abstract][Full Text] [Related]
12. Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.
Abe M; Kimura M; Araoka H; Taniguchi S; Yoneyama A
Med Mycol; 2014 Nov; 52(8):835-40. PubMed ID: 25349254
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative.
Clancy CJ; Nguyen MH
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):54-57. PubMed ID: 30316561
[TBL] [Abstract][Full Text] [Related]
14.
Beyda ND; Amadio J; Rodriguez JR; Malinowski K; Garey KW; Wanger A; Ostrosky-Zeichner L
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898999
[TBL] [Abstract][Full Text] [Related]
15. T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study.
Muñoz P; Vena A; Machado M; Martínez-Jiménez MC; Gioia F; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv13-iv19. PubMed ID: 29608752
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Rapid Fungal Detection Panel for Identification of Candidemia at an Academic Medical Center.
Bomkamp JP; Sulaiman R; Hartwell JL; Desai A; Winn VC; Wrin J; Kussin ML; Hiles JJ
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31852762
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia.
Kazancioglu S; Bastug A; Kayaaslan B; Mutlu NM; Calci E; Turhan T; Mumcuoglu I; Akinci E; Bodur H
J Infect Dev Ctries; 2022 Feb; 16(2):362-368. PubMed ID: 35298433
[TBL] [Abstract][Full Text] [Related]
19. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.
Clancy CJ; Pappas PG; Vazquez J; Judson MA; Kontoyiannis DP; Thompson GR; Garey KW; Reboli A; Greenberg RN; Apewokin S; Lyon GM; Ostrosky-Zeichner L; Wu AHB; Tobin E; Nguyen MH; Caliendo AM
Clin Infect Dis; 2018 May; 66(11):1678-1686. PubMed ID: 29438475
[TBL] [Abstract][Full Text] [Related]
20. Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis.
Mikulska M; Giacobbe DR; Furfaro E; Mesini A; Marchese A; Del Bono V; Viscoli C
Clin Microbiol Infect; 2016 Jul; 22(7):646.e5-8. PubMed ID: 27256062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
